Pharma Reviews: Cipla finally delivers growth in the March quarter, all eyes on FY20 now

In India, it expects to grow faster than the 8-10% market growth. ... The last two years have been difficult for Indian pharma due to changes in tax policy ...
Read more: Cipla finally delivers growth in the March quarter, all eyes on FY20 now